-
Study aim
-
Determining and comparing the effect of topical injection of "morphine, triamcinolone and lidocaine" and "lidocaine" on pain intensity after mastoidectomy-tympanoplasty
-
Design
-
A randomized, double-blinding clinical trial, with the parallel groups, Phase 3 on 68 patients
-
Settings and conduct
-
In this randomized double-blind clinical trial study, 68 eligible patients referred to Alzahra and Kashani hospitals in Isfahan will be included in the study and will be randomly divided into two groups. Before anesthesia, the first group will receive a topical injection of a combination of morphine, triamcinolone, and lidocaine, and the second group will receive a topical injection of lidocaine. Then the patients' pain score and hemodynamic parameters will be evaluated and compared between the two groups.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria include 15 to 65 years of age, indication for mastoidectomy-tympanoplasty, and consent to participate in the study. Exclusion criteria include having a history of drug and alcohol addiction, having a history of seizures and mental health problems, having kidney disease, and dying.
-
Intervention groups
-
Intervention group: In this group, 0.15 mg/kg morphine (Daru Pakhsh Company) and 10 mg triamcinolone (Germany Hexal Company) to 100 mg lidocaine 2% (Aburaihan Tehran) and epinephrine with a concentration of 1 to 100,000 (Daru Pakhsh Company) are added and injected topically by the surgeon at the surgical incision site before surgery.
Control group: In this group, according to the usual method, 0.15 mg/kg morphine (Daru Pakhsh Company) is injected intravenously before surgery. Then, 100 mg of lidocaine 2% (Aburaihan Company) and epinephrine with a concentration of 1 to 100,000 (Daru Pakhsh Company) are injected topicaly at the surgical incision site before surgery.
-
Main outcome variables
-
Pain; Hemodynamic parameter